{"symbol": "AUTL", "companyName": "Autolus Therapeutics plc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "https://www.autolus.com", "description": "Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.", "CEO": "Christian Itin", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}